JPM vs MAAS
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
JPM exhibits a concerning Piotroski F-Score of 2/9, indicating weak short-term fundamental health, and currently trades at a significant premium to both its Graham Number ($239.11) and Intrinsic Value ($140.07). While the company maintains a strong ROE of 16.13% and dominant market positioning, negative YoY earnings growth (-3.60%) and bearish insider activity from the CEO and CFO signal internal caution. The stock's current price of $313.68 suggests the market is pricing in a growth premium that is not currently supported by the deterministic health or value metrics.
Maase Inc. presents a precarious financial profile characterized by a Piotroski F-Score of 4/9, indicating only marginal stability despite severe underlying liquidity issues. The company is facing a critical solvency crisis with a Current Ratio of 0.12 and a Quick Ratio of 0.04, suggesting it cannot meet its short-term obligations. While the stock has experienced a speculative short-term rally (+100.3% in 6 months), this is completely decoupled from fundamentals, as evidenced by an astronomical Price/Sales ratio of 549.33 and negative profit margins. The long-term trajectory remains catastrophic with a 5-year price decline of 97.5%.
Compare Another Pair
Related Comparisons
JPM vs MAAS: Head-to-Head Comparison
This page compares JPMorgan Chase & Co. (JPM) and Maase Inc. (MAAS) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.